(No title) August 27, 2020 – Posted in: Tiziana Life Sciences (TILS)

27th August, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Tiziana Life Sciences CEO Updates Shareholders on its Patent Portfolio, Clinical Pipeline, and Strategy in an Exclusive Interview  Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, today announced that an interview with its CEO and CSO Dr. Kunwar Shailubhai is now available.  In the interview,…

Continue reading